butyrylcholinesterase inhibitors (China Pharmaceutical University/Friedrich-Schiller-Universitat Jena/King Saud University)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug Namebutyrylcholinesterase inhibitors (China Pharmaceutical University/Friedrich-Schiller-Universitat Jena/King Saud University)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCholinesterase inhibitors
TargetsCholinesterase
Therapy Area/IndicationsAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySaudi ArabiaDenmarkMainland China
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaPending
Originator CompaniesChina Pharmaceutical University
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesFriedrich-Schiller-Universität JenaKing Saud UniversityChina Pharmaceutical University
Active IndicationsN/A
Inactive IndicationsAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A